Source: Annual Congress 2002 - Pneumonias: aetiology; management; antimicrobial resistance; empyema
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Sawai, N. Saku, K. Oshikawa, S. Ohno, Y. Sugiyama (Minamikawachi, Tochigi, Japan). The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection. Eur Respir J 2002; 20: Suppl. 38, 2209

Member's Comments

No comment yet.

Related content which might interest you: What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Treatment challenges in methicillin resistant Staphylococcus aureus infections Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Significance of methicillin-resistant staphylococcus aureus in lower respiratory tract infections Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant staphylococcus aureus (CA-MRSA) Source: Eur Respir J 2007; 30: Suppl. 51, 407s Year: 2007 An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Source: Eur Respir J 2010; 36: 901-906 Year: 2010 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Community-associated methicillin-resistant staphylococcus aureus (CA-MRSA) as a cause of hospital-acquired pneumonia (HAP) Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Staphlococcus aureus: susceptibility to antibacterial drugs and rate of MRSA Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006 Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Successful eradication of methicillin-resistant staphylococcus aureus in chronically colonized cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 The antimicrobial molecule elafin protects the lung against Staphylococcus aureus infection Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Community-acquired pneumonia due to S. aureus Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Immunomodulating effect of clarithromycin in a murine model of mycoplasma pneumoniae pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 737s Year: 2007 MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia Source: Eur Respir J 2009; 34: 1470-1476 Year: 2009 Molecular epidemiology and antimicrobial resistance of methicillin-resistant staphylococcus aureus isolated from nasal swab at intensive care unit Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008